Technology | April 14, 2011

FDA Clears Brachytherapy Treatment Planning Software

April 14, 2011 – The U.S Food and Drug Administration (FDA) has cleared a new brachytherapy treatment planning system for permanent seed implants. The MIM Symphony module, from MIM Software, provides a powerful combination of tools to benefit radiation oncologists working with brachytherapy.

MRI, CT and even molecular imaging can now be seamlessly integrated into treatment planning for increased quality assurance.

“Brachytherapists can now enjoy the same image display, fusion and manipulation tools as their colleagues in radiology, and the same contouring tools as their colleagues performing IMRT – all directly integrated into the brachytherapy treatment planning software,” said Jonathan Piper, director of research and business development at MIM Software.

Key to the software is the new ReSlicer tool. For treatments requiring needle insertions that aren’t precisely perpendicular to the imaging plane, ReSlicer allows images to be quickly and easily reoriented, ensuring accurate planning and dosimetry for otherwise complicated plans. The tool adds confidence and simplicity to breast, lung, liver and other treatments.

“Our goal was to achieve totally flexible seed placement,” Piper said. “The use of ReSlicer in conjunction with thin-slice imaging allows for more precise planning and better orientation of seeds within the patient. In addition, fusion with mo¬dalities such as MRI offers more accurate contouring of targets and the possibility of dose escalation.”

The software seamlessly integrates many of the tools found in MIM Maestro, the company’s radiation oncology product. Using dose accumulation, it can sum a brachytherapy plan with any other DICOM dose file, giving an accurate representation of the full dose delivered to the patient. This can be essential to identifying and compensating for hot spots and underdoses, and provides much more confidence than reviewing two separate dose volume histograms.

Post-implant quality assurance is much more accurate. Multi-modality fusion allows either the original planning image or a separate post-implant image, such as an MRI, to be registered to a post-implant CT for more reliable target contouring. Combined with seed localization accuracy, which exceeds the resolution of the CT image, post-implant dosimetry is both easy and exact.

For more information: www.mimsoftware.com

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
California Women In Favor of Extending State's Breast Density Inform Law
News | Breast Density | June 15, 2018
A recent survey of California women found that 95 percent of respondents want the state’s breast density inform law to...
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
How AI and Deep Learning Will Enable Cancer Diagnosis Via Ultrasound

The red outline shows the manually segmented boundary of a carcinoma, while the deep learning-predicted boundaries are shown in blue, green and cyan. Copyright 2018 Kumar et al. under Creative Commons Attribution License.

News | Ultrasound Imaging | June 12, 2018 | Tony Kontzer
June 12, 2018 — Viksit Kumar didn’t know his mother had...
Breast imaging technologies have seen a rapid evolution.

Breast imaging technologies have seen a rapid evolution.

Feature | Women's Health | June 05, 2018 | By Jeff Zagoudis
Breast imaging technologies have evolved rapidly in the last two decades to help physicians detect breast cancers at
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Lung Decision Precision
News | Lung Cancer | June 04, 2018
For smokers and former smokers, the threat of lung cancer always lurks in the shadows.
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init